Choose your preferred way to stay informed of new case launches and settlement deadlines
The filed complaint alleges that Medpace Holdings, Inc. made materially false and/or misleading statements and/or failed to disclose that: Jefferies downgraded Medpace, citing perceived weaknesses in the Company's business model as a contract research organization amid pressure on biotechnology funding. Following this news, Medpace's stock price fell over 9% on September 25, 2024.
In order to be eligible to join the MEDP class action lawsuit, you must have incurred a loss on shares of Medpace Holdings, Inc. purchased during the class period listed above.
TOP
